PRNewsWire - Health

Rebel Medicine Announces Series A Financing and Investigational New Drug (IND) Application Opening to Advance Non‑Opioid Pain Therapeutic into Clinical Development
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
Mosquito Joe® Urges Prevention as Summer Mosquito Threat Looms
Vascarta Receives FDA Orphan Drug Designation for Vasceptor® in the Treatment of Sickle Cell Disease